(NYSE: ATR) Aptargroup's forecast annual revenue growth rate of 4.04% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 9.32%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.68%.
Aptargroup's revenue in 2025 is $3,582,890,000.On average, 4 Wall Street analysts forecast ATR's revenue for 2025 to be $242,298,540,922, with the lowest ATR revenue forecast at $239,516,045,386, and the highest ATR revenue forecast at $247,056,611,612. On average, 4 Wall Street analysts forecast ATR's revenue for 2026 to be $256,721,369,973, with the lowest ATR revenue forecast at $253,147,580,451, and the highest ATR revenue forecast at $261,067,169,847.
In 2027, ATR is forecast to generate $275,289,848,067 in revenue, with the lowest revenue forecast at $275,289,183,114 and the highest revenue forecast at $275,290,513,020.